
Prince Akwasi Mensah
Examiner (ID: 16550, Phone: (571)270-7183 , Office: P/2474 )
| Most Active Art Unit | 2474 |
| Art Unit(s) | 2416, 2474 |
| Total Applications | 590 |
| Issued Applications | 431 |
| Pending Applications | 63 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 09/529687 | NOVEL USE OF COMPOUNDS FOR ANTI-PRURITIC ACTIVITY | Apr 16, 2000 | Abandoned |
| 09/550736 | Treatment of congestive heart failure | Apr 16, 2000 | Abandoned |
Array
(
[id] => 4277726
[patent_doc_number] => 06281239
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Method of treating onychomycosis'
[patent_app_type] => 1
[patent_app_number] => 9/547841
[patent_app_country] => US
[patent_app_date] => 2000-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2555
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281239.pdf
[firstpage_image] =>[orig_patent_app_number] => 547841
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/547841 | Method of treating onychomycosis | Apr 11, 2000 | Issued |
Array
(
[id] => 4314622
[patent_doc_number] => 06248371
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Metal/thiol biocides'
[patent_app_type] => 1
[patent_app_number] => 9/543880
[patent_app_country] => US
[patent_app_date] => 2000-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20362
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248371.pdf
[firstpage_image] =>[orig_patent_app_number] => 543880
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/543880 | Metal/thiol biocides | Apr 5, 2000 | Issued |
Array
(
[id] => 6511718
[patent_doc_number] => 20020025969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'USE OF PHOSPHORDIESTERASE INHIBITORS IN THE TREATMENT OF PROSTATIC DISEASES'
[patent_app_type] => new
[patent_app_number] => 09/462090
[patent_app_country] => US
[patent_app_date] => 2000-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2694
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025969.pdf
[firstpage_image] =>[orig_patent_app_number] => 09462090
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/462090 | USE OF PHOSPHORDIESTERASE INHIBITORS IN THE TREATMENT OF PROSTATIC DISEASES | Apr 5, 2000 | Abandoned |
Array
(
[id] => 4346540
[patent_doc_number] => 06284770
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Medicaments for the treatment of non-constipated female irritable bowel syndrome'
[patent_app_type] => 1
[patent_app_number] => 9/529050
[patent_app_country] => US
[patent_app_date] => 2000-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4174
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284770.pdf
[firstpage_image] =>[orig_patent_app_number] => 529050
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/529050 | Medicaments for the treatment of non-constipated female irritable bowel syndrome | Apr 4, 2000 | Issued |
Array
(
[id] => 1561879
[patent_doc_number] => 06362220
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-26
[patent_title] => 'Anticonvulsant derivatives useful in reducing blood glucose levels'
[patent_app_type] => B1
[patent_app_number] => 09/538803
[patent_app_country] => US
[patent_app_date] => 2000-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1842
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/362/06362220.pdf
[firstpage_image] =>[orig_patent_app_number] => 09538803
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/538803 | Anticonvulsant derivatives useful in reducing blood glucose levels | Mar 29, 2000 | Issued |
Array
(
[id] => 4418889
[patent_doc_number] => 06194430
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Viral treatment'
[patent_app_type] => 1
[patent_app_number] => 9/538006
[patent_app_country] => US
[patent_app_date] => 2000-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11495
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194430.pdf
[firstpage_image] =>[orig_patent_app_number] => 538006
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/538006 | Viral treatment | Mar 28, 2000 | Issued |
Array
(
[id] => 4261332
[patent_doc_number] => 06258831
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Viral treatment'
[patent_app_type] => 1
[patent_app_number] => 9/535172
[patent_app_country] => US
[patent_app_date] => 2000-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10635
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258831.pdf
[firstpage_image] =>[orig_patent_app_number] => 535172
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/535172 | Viral treatment | Mar 26, 2000 | Issued |
Array
(
[id] => 4272316
[patent_doc_number] => 06245788
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Viral treatment'
[patent_app_type] => 1
[patent_app_number] => 9/535173
[patent_app_country] => US
[patent_app_date] => 2000-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6989
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245788.pdf
[firstpage_image] =>[orig_patent_app_number] => 535173
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/535173 | Viral treatment | Mar 26, 2000 | Issued |
Array
(
[id] => 1586456
[patent_doc_number] => 06359007
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Clinical uses for L-arginine ascorbate and various metalloarginate complexes'
[patent_app_type] => B1
[patent_app_number] => 09/534909
[patent_app_country] => US
[patent_app_date] => 2000-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5577
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/359/06359007.pdf
[firstpage_image] =>[orig_patent_app_number] => 09534909
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/534909 | Clinical uses for L-arginine ascorbate and various metalloarginate complexes | Mar 22, 2000 | Issued |
Array
(
[id] => 4330403
[patent_doc_number] => 06313090
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Methods for treating parasitic infection using thiopeptides'
[patent_app_type] => 1
[patent_app_number] => 9/446765
[patent_app_country] => US
[patent_app_date] => 2000-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8157
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/313/06313090.pdf
[firstpage_image] =>[orig_patent_app_number] => 446765
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446765 | Methods for treating parasitic infection using thiopeptides | Mar 19, 2000 | Issued |
Array
(
[id] => 6740845
[patent_doc_number] => 20030158214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'REMEDIAL AGENT FOR NEURAL DEGENERATION'
[patent_app_type] => new
[patent_app_number] => 09/486823
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3519
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158214.pdf
[firstpage_image] =>[orig_patent_app_number] => 09486823
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/486823 | Remedial agent for neural degeneration | Mar 2, 2000 | Issued |
Array
(
[id] => 1441266
[patent_doc_number] => 06335356
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-01
[patent_title] => 'Method of treating a patient by parenteral administration of a lipophilic compound'
[patent_app_type] => B1
[patent_app_number] => 09/516424
[patent_app_country] => US
[patent_app_date] => 2000-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4581
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/335/06335356.pdf
[firstpage_image] =>[orig_patent_app_number] => 09516424
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/516424 | Method of treating a patient by parenteral administration of a lipophilic compound | Feb 29, 2000 | Issued |
| 09/511952 | Method for improving disturbancies of activities of daily living after stroke | Feb 22, 2000 | Abandoned |
Array
(
[id] => 6414198
[patent_doc_number] => 20020183357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Use of alpha- 1- alpha adrenoceptor agonists with alpha-1-Beta antagonism for the treatment of stress urinary incontinence'
[patent_app_type] => new
[patent_app_number] => 09/507178
[patent_app_country] => US
[patent_app_date] => 2000-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4219
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20020183357.pdf
[firstpage_image] =>[orig_patent_app_number] => 09507178
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/507178 | Use of alpha- 1- alpha adrenoceptor agonists with alpha-1-Beta antagonism for the treatment of stress urinary incontinence | Feb 16, 2000 | Abandoned |
Array
(
[id] => 1457843
[patent_doc_number] => RE037564
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2002-02-26
[patent_title] => 'Composition for contraception'
[patent_app_type] => E1
[patent_app_number] => 09/503952
[patent_app_country] => US
[patent_app_date] => 2000-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2662
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/037/RE037564.pdf
[firstpage_image] =>[orig_patent_app_number] => 09503952
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/503952 | Composition for contraception | Feb 14, 2000 | Issued |
Array
(
[id] => 1572586
[patent_doc_number] => RE037838
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2002-09-10
[patent_title] => 'Composition for contraception'
[patent_app_type] => E1
[patent_app_number] => 09/504084
[patent_app_country] => US
[patent_app_date] => 2000-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2634
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/037/RE037838.pdf
[firstpage_image] =>[orig_patent_app_number] => 09504084
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/504084 | Composition for contraception | Feb 14, 2000 | Issued |
| 09/499864 | Medicament | Feb 6, 2000 | Abandoned |
Array
(
[id] => 4419202
[patent_doc_number] => 06194459
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants'
[patent_app_type] => 1
[patent_app_number] => 9/485022
[patent_app_country] => US
[patent_app_date] => 2000-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2914
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194459.pdf
[firstpage_image] =>[orig_patent_app_number] => 485022
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/485022 | Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants | Feb 1, 2000 | Issued |